Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia
December 1, 2025 |
For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.
Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come.
Among the proven benefits of Medscape AI:
- Reliability: Clinically Vetted Sources, Transparent By Design
- Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
- AI responses are traceable, transparent, and supported by citations
- Recency: Always Current and Continuously Updated
- Integrates verified real-time news, research updates, and guideline changes
- Daily and weekly editorial oversight ensures outputs reflect the latest evidence
- Relevance: Aligned to Practice and Patient Care
- Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
- Synthesized insights tuned to each specialty, workflow, and clinical context
- Guidance supports differential diagnosis, treatment decisions, and next-step care
- Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools
- Time-Saving Clinical Efficiency
- Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature
“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”
Medscape is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month.
Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!
Educational Symposia
Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.
- Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
- Time: 11:30 AM – 1:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International HIJK
- Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
- Time: 11:30 AM – 1:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International DEFG
- Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
- Time: 11:30 AM – 1:00 PM ET
- Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
- Room: W311 EFGH
- Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
- Time: 3:30 PM – 5:00 PM ET
- Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
- Room: W311 EFGH
- Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
- Time: 3:30 PM – 5:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International HIJK
ASH Abstract Publication
Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood.
For more information, please contact Jelena Spyropoulos.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Heart and Mouth Connection Every Woman Needs to Know
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
Uncovering Inequities in Alzheimer’s Disease Screening and Care
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...
Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...
What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?
Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...
“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards
Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...
Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia
For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...
Women Leaders Rewriting the Protocols of Rare Disease Care
The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...